Clinical studies of Norpace (Part III).
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004206:Disopyramide / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D011725:Pyridines / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D011725:Pyridines; D004206:Disopyramide